According to the experts that we spoke to, the death, which followed an intravenous NAD⁺ infusion that went catastrophically wrong, underscores the risks of unproven treatments and the need for rigorous longevity medicine.
Earlier this week, Elizabeth Baron, a 27-year-old woman from New York City, died after receiving an intravenous infusion at a local “wellness clinic.” The procedure was performed by 55-year-old Luis Rojas Cabrera, the owner of Bereshit Lifestyle Center. Cabrera was taken into custody by the NYPD and charged with reckless endangerment and unauthorized practice of a profession. He was later released without bail but ordered to surrender his passport. Cabrera claims to have completed his medical training in the Dominican Republic, but he is not licensed to practice medicine in the United States.
One person dies taking a non standard of care treatment makes headlines.
3,000 or more people die annually talking aspirin.
AI-generated answer.
Please verify critical facts.
Estimates for annual deaths associated with long-term daily aspirin use vary by population and study, but research suggests approximately 3,000 deaths per year occur in the UK due to major bleeds caused by the drug. In the United States, risk assessments indicate a mortality risk of 10.4 deaths per 100,000 men per year for those taking a full-sized 325 mg aspirin daily for prevention.
Recent large-scale trials provide specific data on mortality risks:
- ASPREE Trial : Found an excess of 1.6 deaths per 1,000 person-years among healthy older adults (average age 74) taking low-dose aspirin, primarily driven by cancer-related mortality.
- Age-Related Risk : The risk of fatal or disabling gastrointestinal bleeding is significantly higher in patients over 75, with annual bleed rates reaching 5% for those aged 85 and over.
- Overdose Risk : The chance of death from an acute aspirin overdose is approximately 1 percent , with 16 percent of survivors experiencing lasting side effects.
These figures highlight a balance between benefits and risks, particularly for primary prevention in healthy older adults, where bleeding risks may outweigh cardiovascular benefits.
AI-generated answer.
Please verify critical facts.